Mingyu, W., Wenwen, Z., Guangyan, C., Juan, X., & Pengpeng, Q. Serum-derived exomiR-188-3p is a promising novel biomarker for early-stage ovarian cancer. De Gruyter.
Chicago Style (17th ed.) CitationMingyu, Wang, Zhang Wenwen, Cheng Guangyan, Xu Juan, and Qu Pengpeng. Serum-derived ExomiR-188-3p Is a Promising Novel Biomarker for Early-stage Ovarian Cancer. De Gruyter.
MLA (9th ed.) CitationMingyu, Wang, et al. Serum-derived ExomiR-188-3p Is a Promising Novel Biomarker for Early-stage Ovarian Cancer. De Gruyter.
Warning: These citations may not always be 100% accurate.